Viewing StudyNCT06422520



Ignite Creation Date: 2024-06-16 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06422520
Status: RECRUITING
Last Update Posted: 2024-05-21
First Post: 2024-05-15

Brief Title: A First-in-Human Study of BGB-C354 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors
Sponsor: BeiGene
Organization: BeiGene

Conditions & Keywords Data

Conditions:
Name
Advanced Solid Tumor
Keywords:
Name View
BGB-C354 View
Tislelizumab View
First-in-human View
Advanced solid tumor View
Anti-PD-1 Monoclonal Antibody View
B7H3 View
antibody drug conjugate View